Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Study to Evaluate the Safety and Cardiovascular Effects of Algisyl-LVR™ as a Method of Left Ventricular Augmentation in Patients With Dilated Cardiomyopathy (AUGMENT-HF)

NCT01311791 is registered in ClinicalTrials.gov with LoneStar Heart, Inc. as lead sponsor.

NCT NCT01311791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01311791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Study to Evaluate the Safety and Cardiovascular Effects of Algisyl-LVR™ as a Method of Left Ventricular Augmentation in Patients With Dilated Cardiomyopathy (AUGMENT-HF)
Lead sponsor
LoneStar Heart, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2012
Completion date
May 31, 2016
Enrollment
78 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, heart failure